Jump to content
RemedySpot.com

Clinical Trial for new HCV med

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 11

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV

Genotypes

From the PharmaLive.com News Archive - Mar. 30, 2011

Pharmasset announced today that screening has begun in a Phase 2b study of

PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic

hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD with pegylated

interferon and ribavirin in patients with HCV genotype 1, 4, 5 or 6 who have not

been treated previously.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...